Multiple effects of honokiol on the life cycle of hepatitis C virus
- 11 August 2011
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 32 (6), 989-997
- https://doi.org/10.1111/j.1478-3231.2011.02621.x
Abstract
Background Honokiol, a small active molecular compound extracted from magnolia, has recently been shown to inhibit hepatitis C virus (HCV) infection in vitro. Aims This study further characterized aspects of the HCV lifecycle affected by the antiviral functions of honokiol. Methods The influence of honokiol on HCV infection, entry, translation and replication was assessed in Huh-7.5.1 cells using cell culture-derived HCV (HCVcc), HCV pseudo-type (HCVpp) and sub-genomic replicons. Results Honokiol had strong antiviral effect against HCVcc infection at non-toxic concentrations. Combined with interferon-α, its inhibitory effect on HCVcc was more profound than that of ribavirin. Honokiol inhibited the cell entry of lentiviral particles pseudo-typed with glycoproteins from HCV genotypes 1a, 1b, and 2a, but not of the vesicular stomatitis virus. It had inefficient activity on HCV internal ribosome entry site (IRES)-translation at concentrations with significant anti-HCVcc effects. The expression levels of components of replication complex, NS3, NS5A and NS5B, were down-regulated by honokiol in a dose-dependent manner. It also inhibited HCV replication dose dependently in both genotypes 1b and 2a sub-genomic replicons. Conclusions Honokiol inhibits HCV infection by targeting cell entry and replication and, only at a concentration >30 μM, IRES-mediated translation of HCV life cycle. Based on its high therapeutic index (LD50/EC90 = 5.4), honokiol may be a promising drug for the treatment of HCV infection.This publication has 45 references indexed in Scilit:
- Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatmentJCI Insight, 2010
- Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infectionProceedings of the National Academy of Sciences of the United States of America, 2009
- Refractoriness of hepatitis C virus internal ribosome entry site to processing by Dicer in vivoJournal of Negative Results in BioMedicine, 2009
- Honokiol, a Multifunctional Antiangiogenic and Antitumor AgentAntioxidants and Redox Signaling, 2009
- Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and SecretionJournal of Virology, 2008
- Honokiol Induces Calpain-Mediated Glucose-Regulated Protein-94 Cleavage and Apoptosis in Human Gastric Cancer Cells and Reduces Tumor GrowthPLOS ONE, 2007
- Hepatitis C Virus p7 and NS2 Proteins Are Essential for Production of Infectious VirusJournal of Virology, 2007
- Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnololBioorganic & Medicinal Chemistry Letters, 2007
- Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteinsProceedings of the National Academy of Sciences of the United States of America, 2007
- Facile Purification of Honokiol and Its Antiviral and Cytotoxic PropertiesJournal of Medicinal Chemistry, 2006